phase readout
saveNCT07095933: The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy
RECRUITINGupdated 2mo ago
community read0 votes
Sponsor: Xuanwu Hospital, Beijing. Phase: EARLY_PHASE1. Conditions: Epilepsy, Drug Resistant
view source ↗
comments(0)
5-min edit window · permanent after that